Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies
Clinical trial NCT03467152 · COMPLETED
Trial details
- NCT number
- NCT03467152
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-04
- Primary completion
- 2020-04-15
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.